GB0618403D0 - Treatment of amyotrophic lateral sclerosis - Google Patents

Treatment of amyotrophic lateral sclerosis

Info

Publication number
GB0618403D0
GB0618403D0 GBGB0618403.0A GB0618403A GB0618403D0 GB 0618403 D0 GB0618403 D0 GB 0618403D0 GB 0618403 A GB0618403 A GB 0618403A GB 0618403 D0 GB0618403 D0 GB 0618403D0
Authority
GB
United Kingdom
Prior art keywords
treatment
lateral sclerosis
amyotrophic lateral
amyotrophic
sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0618403.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB0618403.0A priority Critical patent/GB0618403D0/en
Publication of GB0618403D0 publication Critical patent/GB0618403D0/en
Priority to PCT/BE2007/000107 priority patent/WO2008034202A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0618403.0A 2006-09-19 2006-09-19 Treatment of amyotrophic lateral sclerosis Ceased GB0618403D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0618403.0A GB0618403D0 (en) 2006-09-19 2006-09-19 Treatment of amyotrophic lateral sclerosis
PCT/BE2007/000107 WO2008034202A2 (fr) 2006-09-19 2007-09-19 Traitement de la sclérose latérale amyotrophique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0618403.0A GB0618403D0 (en) 2006-09-19 2006-09-19 Treatment of amyotrophic lateral sclerosis

Publications (1)

Publication Number Publication Date
GB0618403D0 true GB0618403D0 (en) 2006-11-01

Family

ID=37421218

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0618403.0A Ceased GB0618403D0 (en) 2006-09-19 2006-09-19 Treatment of amyotrophic lateral sclerosis

Country Status (2)

Country Link
GB (1) GB0618403D0 (fr)
WO (1) WO2008034202A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9351988B2 (en) 2011-05-02 2016-05-31 Universite De Geneve Macrocyclic lactones and use thereof
CN102872066B (zh) 2012-10-19 2014-07-02 厦门大学 伊维菌素及其衍生物的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189026A (en) * 1991-06-07 1993-02-23 Fractal Laboratories, Inc. Treatment of human diseases involving dysregulation or dysfunction of the nervous system
FR2790670A1 (fr) * 1999-03-12 2000-09-15 Aventis Pharma Sa Association riluzole et antagoniste des recepteurs ampa
JP2002047206A (ja) * 2000-07-28 2002-02-12 Taisho Pharmaceut Co Ltd Ｇｄｎｆ産生促進剤、パーキンソン病治療剤およびａｌｓ治療剤
GB0504995D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Use of a compound

Also Published As

Publication number Publication date
WO2008034202A3 (fr) 2008-06-19
WO2008034202A2 (fr) 2008-03-27

Similar Documents

Publication Publication Date Title
HK1251156A1 (zh) 結節性硬化症治療
IL212992A0 (en) Treatment of amyotrophic lateral sclerosis
GB0605337D0 (en) Treatment of CNS conditions
EP2068864A4 (fr) Utilisations thérapeutiques d'urolithines
GB0610867D0 (en) Treatment of pain
IL197315A0 (en) Treatment of cancer
IL193748A0 (en) Treatment of pain
EP2046349A4 (fr) Traitement de la néovascularisation excessive
ZA200903772B (en) Treatment of pervasive developmental disorders
GB0619500D0 (en) Treatment of fibrosis
EP2306830A4 (fr) Utilisation de mifépristone pour le traitement de la sclérose latérale amyotrophique
ZA201000225B (en) Treatment of depression
EP2050467A4 (fr) Agent thérapeutique destiné à la sclérose latérale amyotrophique
GB0610868D0 (en) Treatment of pain
GB0607952D0 (en) Novel treatment
GB0618403D0 (en) Treatment of amyotrophic lateral sclerosis
IL194798A0 (en) Treatment of melanoma
GB0611417D0 (en) Treatment of cndaria intoxication
GB0616450D0 (en) Treatment of pain
GB0623740D0 (en) Treatment of disease
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0602857D0 (en) The treatment of sialorrhoea
GB0600903D0 (en) Treatment of cancer
GB0625602D0 (en) Treatment of sialorrhoea
GB0609792D0 (en) The treatment of multiple sclerosis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)